Skip to content

Hysteroscopic Isthmocele Repair on IVF Outcome

Effect of Hysteroscopic Isthmocele Repair on IVF Outcome: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05590104
Enrollment
50
Registered
2022-10-21
Start date
2023-03-26
Completion date
2024-05-30
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section; Dehiscence, Intrauterine Disorder, Reproductive Issues

Brief summary

Hysteroscopic Isthmocele repair on IVF outcome It aims to assesse the efficacy of Hysteroscopic CS scar defect repair on the clinical pregnancy rate after embryo transfer. Patients who were diagnosed with significant caesarean section scar defect and had a previous unsuccessful ongoing pregnancy after embryo transfer of one or more euploid embryo and planning for another trial of one euploid embryo transfer will be assed for study eligibility. Twenty five of them will be be randomized to hysteroscopic repair before having embryo transfer. and 25 will go directly for embryo transfer. Clinical pregnancy rate is the primary outcome.

Detailed description

Hysteroscopic Isthmocele repair on IVF outcome Background: Uterine niche is a very common finding in women with previous caesarean section. Subfertility can be associated finding and IVF outcome can be affected by its presence. It is not yet if its treatment before IVF trial could improve the outcome of IVF cycle. Objectives: assesse the efficacy of Hysteroscopic CS scar defect repair on the clinical pregnancy rate after embryo transfer. Methods This prospective randomized controled will be conducted at Healthplus fertility center. The population of the study will be Patients who was diagnosed with significant caesarean section scar defect and had a previous unsuccessful ongoing pregnancy after embryo transfer of one or more euploid embryo and planning for another trial of one euploid embryo transfer. Twenty five of them will be be randomized to hysteroscopic repair before having embryo transfer. and 25 will go directly for embryo transfer. Clinical pregnancy rate is the primary outcome. Seconday outcomes are Complications following hysteroscopic CS scar repair, the need of aspiration of intrauterine fluid before embryo transfer, early pregnancy complications, Caesarean section scar dehiscence or rupture and live birth rate.

Interventions

PROCEDUREHysteroscopic CS scar defect repair

Dilatation of the cervix till 7 mm. Introduce the resctoscope through the cervix. The surgical correction of the isthmocele is done by resection of the inferior and superior edges or just the inferior edge of the defect with a resectoscopic loop, using pure cutting current, until reaching the muscular layer. Coagulation of fragile vessels at the base or even entire niche. At the end of procedure, flow and pressure of distending medium can be reduced to ensure adequate haemostasis.

Sponsors

HealthPlus Fertility Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

The allocated groups will be concealed in serially-numbered sealed opaque envelops that was only opened just after recruitment. Women in any of the groups will receive the allocated treatment after their approval to participate in the study.

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed CS scar defect by TVUS * At least one failed trial of euploid embryo transfer * Planning for a trial of single euploid embryo transfer

Exclusion criteria

* Residual myometrial thickness less than 3 mm * Any congenital uterine abnormalities., * Prescence of intrauterine lesions e.g. polyp, fibroid, Endometriosis or adenomyosis, Hydrosalpinx, Chronic endometritis, Previous CS scar defect repair.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Clinical pregnancyat 7 weeks of gestation or beyonddetection of intrauterine pregnancy with a detectable fetal heart pulsation by transvaginal ultrasound scan

Secondary

MeasureTime frameDescription
Rate of Complications following hysteroscopic CS scar repairup to 6 weeksuterine perforation, fluid overload and endometritis
Rate of Need of aspiration of intrauterine fluidDuring the preparation of embryo transfer. Through study completion, an average of 1 yearPresence intrauterine fluid collection at the time of embryo transfer which should be aspirated before embryo transfer
Rate of Early pregnancy complications12 weeks gestationEctopic pregnancy or Miscarriage
Rate of Caesarean section scar dehiscence or ruptureWithin 40 weeks of pregnancyRupture of CS scar during the antenatal period or presence of CS scar wound dehiscence at the time of delivery
Rate of delivery of a living babyWithin 40 weeks of pregnancyDelivery of a living baby after 24 weeks gestation

Countries

United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026